Latest News and Press Releases

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 17 July 2023 – 17:45 CEST – Mithra...

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 4 July 2023 – [17:45 CEST] – Mithra...

Mithra Announces Information on the Total Number of Voting Rights (Denominator) Liege, Belgium, 26 June 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s...

Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility Liege, Belgium, 21 June 2023 – 17:50 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the...

Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor activityLead compound shows synergy with PD1 cancer immune checkpoint...

Publication of a transparency notification received from Scorpiaux BV Liege, Belgium, 05 June 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today...

Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit Committee Liege, Belgium, 29 May 2023 – 7:30 CEST – Mithra (Euronext...

Mithra’s General Meeting Of Shareholders Approves the Renewal of its Board of Directors Liege, Belgium, 25 MAY 2023 – 5:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to...

Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...

Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...